Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

INVEGA HAFYERA® (paliperidone palmitate 6-month)

Medical Information

+ Save link

Management of an Incomplete Administration of INVEGA HAFYERA

Last Updated: 10/15/2024

Abbreviations: PP1M, paliperidone palmitate 1month; PP3M, paliperidone palmitate 3-month; PP6M, paliperidone palmitate 6-month.
^aNajarian (2021).¹ ^bData on file (2020).² ^cData on file (2021).³ ^dData on file (2022).⁴ ^eINVEGA HAFYERA (paliperidone palmitate) [Prescribing Information].⁵

LITERATURE SEARCH

A literature search of Ovid MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File databases (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 12 September 2024.

References

Show

1	Najarian D, Sanga P, Wang S, et al. A randomized, double-blind, multicenter, noninferiority study comparing paliperidone palmitate 6-Month versus the 3-Month long-acting injectable in patients with schizophrenia. Int J Neuropsychopharmacol. 2022;25(3):238-251.
2	Data on File. A double-blind, randomized, active-controlled, parallel-group study of paliperidone palmitate 6-month formulation. Janssen Research & Development, LLC; Paliperidone Palmitate CSR; 2020.
3	Data on File. Paliperidone palmitate 6-month internal communication. Janssen Research & Development, LLC; 2021.
4	Data on File. Paliperidone palmitate 6-month injection, Version 002. Janssen Research & Development, LLC; Paliperidone Palmitate CCDS; 2022.
5	INVEGA HAFYERA (paliperidone palmitate) extended-release injectable suspension [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+HAFYERA-pi.pdf.